We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DSX icon
13626
CALL
Diana Shipping
DSX
$309M
$9.02K ﹤0.01%
4,600
-17,000
-79% -$36.2K
MILN
13627
CALL
Global X Millennial Consumer ETF
MILN
$103M
$8.99K ﹤0.01%
+200
New +$8.93K
NPCE icon
13628
PUT
Neuropace
NPCE
$507M
$8.95K ﹤0.01%
800
+700
+700% +$6.09K
YDKG
13629
Yueda Digital Holding
YDKG
$5.92M
$8.94K ﹤0.01%
+196
New +$8.89K
QGEN icon
13630
CALL
Qiagen
QGEN
$8.87B
$8.91K ﹤0.01%
194
-37,820
-99% -$1.69M
DXLG icon
13631
CALL
Destination XL Group
DXLG
$35.4M
$8.88K ﹤0.01%
3,300
-17,600
-84% -$47.3K
ORLA
13632
PUT
DELISTED
Orla Mining
ORLA
$8.86K ﹤0.01%
1,600
+1,500
+1,500% +$7.24K
MNY icon
13633
CALL
MoneyHero
MNY
$40.1M
$8.85K ﹤0.01%
7,900
-19,500
-71% -$22.1K
LVO icon
13634
CALL
LiveOne
LVO
$57.2M
$8.82K ﹤0.01%
600
-1,990
-77% -$17.4K
ADAP
13635
PUT
DELISTED
Adaptimmune Therapeutics
ADAP
$8.78K ﹤0.01%
16,300
+10,500
+181% +$7.65K
HBT icon
13636
PUT
HBT Financial
HBT
$1.35B
$8.76K ﹤0.01%
400
-100
-20% -$2.28K
DNTH icon
13637
CALL
Dianthus Therapeutics
DNTH
$6.49B
$8.72K ﹤0.01%
400
IBEX icon
13638
CALL
IBEX
IBEX
$480M
$8.6K ﹤0.01%
400
-500
-56% -$9.83K
CSBR icon
13639
PUT
Champions Oncology
CSBR
$70.4M
$8.57K ﹤0.01%
+1,000
New +$5.03K
HTOO icon
13640
PUT
Fusion Fuel Green
HTOO
$16.8M
$8.56K ﹤0.01%
434
+183
+73% +$3.32K
AQN icon
13641
Algonquin Power & Utilities
AQN
$4.53B
$8.53K ﹤0.01%
1,917
BBT
13642
PUT
Beacon Financial Corp
BBT
$2.69B
$8.53K ﹤0.01%
300
+100
+50% +$2.88K
TSVT
13643
PUT
DELISTED
2seventy bio
TSVT
$8.53K ﹤0.01%
2,900
-1,900
-40% -$7.79K
CIG icon
13644
CALL
CEMIG Preferred Shares
CIG
$5.52B
$8.5K ﹤0.01%
4,800
-10,440
-69% -$20.3K
ORMP icon
13645
PUT
Oramed Pharmaceuticals
ORMP
$186M
$8.47K ﹤0.01%
3,500
+1,400
+67% +$3.33K
APT icon
13646
CALL
Alpha Pro Tech
APT
$55.4M
$8.46K ﹤0.01%
1,600
-21,200
-93% -$116K
OOMA icon
13647
PUT
Ooma
OOMA
$572M
$8.44K ﹤0.01%
600
+500
+500% +$6.67K
LASR icon
13648
PUT
nLIGHT
LASR
$3.03B
$8.39K ﹤0.01%
800
+700
+700% +$7.79K
RES icon
13649
CALL
RPC Inc
RES
$1.41B
$8.32K ﹤0.01%
1,400
-1,300
-48% -$8.06K
SBDS
13650
DELISTED
Solo Brands Inc
SBDS
$8.25K ﹤0.01%
181
-107
-37% -$5.3K

Similar funds

Citadel Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
  • Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.